Are patients, who were previously diagnosed with coronary artery disease by coronary angiography, on optimal medical treatment?

Basit Öğe Kaydı
dc.contributor.authorTemiz, Ahmet
dc.contributor.authorYener, Ali Umit
dc.contributor.authorBarutcu, Ahmet
dc.contributor.authorGazi, Emine
dc.contributor.authorAltun, Burak
dc.contributor.authorBekler, Adem
dc.contributor.authorVural, Ahmet
dc.date.accessioned2025-01-27T20:29:18Z
dc.date.available2025-01-27T20:29:18Z
dc.date.issued2015
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractBackground: This study aims to detect the drug usage rate of patients who had coronary artery disease (CAD) diagnosis by coronary angiogram (CAG). Methods: Reports of 1,549 patients (993 males, 556 females; mean age 62.9 +/- 10.9 years; range 20 to 87 years) (184 normal CAG, 1,365 CAD) who were performed CAG between October 2009 and February 2012 were retrospectively analyzed. Medication data were collected between August 2013 and November 2013 from patients' pharmacy refill data. Usage of aspirin, tienopiridine, statin, angiotensin converting enzyme inhibitor, beta blocker (BB), warfarin, angiotensinogen receptor blocker, nitrate, trimetazidine, calcium channel blocker, and diuretic were recorded. Results: Usage rates of angiotensinogen receptor blocker, trimetazidine, calcium channel blocker, warfarin, diuretic, and fibrate were not statistically different between patients with CAD and normal CAG. Rates of using aspirin (50.3% vs. 39.1%, p=0.005), tienopiridine (25.6% vs. 9.8%, p<0.001), angiotensin converting enzyme inhibitor (38.0% vs. 21.7%, p<0.001), statin (48.5% vs. 30.6%, p<0.001), BB (56.8% vs. 40.2%, p<0.001) and nitrate (15.1% vs. 6.0%, p<0.001) were higher in patients with CAD. Rate of patients using all four drugs, antiplatelet agent, statin, angiotensin converting enzyme inhibitor, and BB was only 13.1% in CAD group. Only 25.8% of patients with CAD used all three of antiplatelet agent, statin, and BB. Conclusion: Patients with CAD are not on optimal medical treatment. These patients should be questioned in every visit in terms of the status of their treatment to administer the optimum medications to reduce cardiovascular mortality and morbidity.
dc.identifier.doi10.5606/tgkdc.dergisi.2015.10448
dc.identifier.endpage257
dc.identifier.issn1301-5680
dc.identifier.issue2
dc.identifier.scopus2-s2.0-84932089845
dc.identifier.scopusqualityQ3
dc.identifier.startpage251
dc.identifier.trdizinid170376
dc.identifier.urihttps://doi.org/10.5606/tgkdc.dergisi.2015.10448
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/170376
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22903
dc.identifier.volume23
dc.identifier.wosWOS:000352520800007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherBaycinar Medical Publ-Baycinar Tibbi Yayincilik
dc.relation.ispartofTurk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectCoronary angiography
dc.subjectcoronary artery disease
dc.subjectmedication adherence
dc.titleAre patients, who were previously diagnosed with coronary artery disease by coronary angiography, on optimal medical treatment?
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu